GLOBAL VACCINE TRACKING
Across the Globe, Rates of Vaccine Skepticism Have Stalled
BY PEYTON SHELBURNE AND JUSTINE COLEMAN | UPDATED: MAY 19, 2022
Morning Consult is conducting over 75,000 weekly interviews across the globe on the COVID-19 vaccine rollout, providing deep insights at a granular level into which countries are most and least opposed to vaccinations, and what factors are driving skepticism. The latest data is based on surveys conducted in 15 countries between May 10-16, 2022, with 32,374 interviews in the United States and between 2,112 to 6,033 interviews in the other 14 countries. Updates will be provided monthly. Get alerts with the latest data.
View our in-depth U.S. tracker.
In order to gauge vaccination rates and interest, Morning Consult asked adults in each country “Have you gotten the vaccine, or not?” Respondents could reply “Yes,” “No, but I will get it in the future,” “No, and I am not sure if I will get it in the future,” or “No, and I do not plan to get it.”
Figures may not add up to 100% due to rounding
Weekly tracking: Over the past five months, rates of vaccine skepticism across the globe have remained relatively stable. Since tracking began, the share of vaccine skeptics has fallen by 8 points in the United States and by an average of 20 points in the other 14 countries.
Methodology
In a given week, Morning Consult conducts around 30,000 interviews in the United States and between 2,000 to 5,000 surveys in each other country on the vaccine rollout, among nationally representative samples of adults. (In India, the sample is representative of the literate population). All interviews are conducted online.
Surveys are weighted in each country by age, gender, region, and, in certain countries, education breakdowns based on official government sources. In the United States, surveys are also weighted by race and ethnicity.
Respondents complete these surveys in languages appropriate for their countries. Professional translation firms in each country conduct the translation and localization.